Measuring schizophrenia remission in clinical practice

被引:15
作者
Alonso, Jordi [1 ]
Ciudad, Antonio [3 ]
Casado, Alfonso [2 ]
Gilaberte, Inmaculada [3 ]
机构
[1] Hosp Mar, Inst Municipal Invest Med, Hlth Serv Res Unit, Barcelona 08003, Spain
[2] Univ Barcelona, E-08007 Barcelona, Spain
[3] Eli Lilly & Co, Madrid, Spain
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2008年 / 53卷 / 03期
关键词
schizophrenia; remission; questionnaires; clinical practice; validity;
D O I
10.1177/070674370805300311
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To evaluate reliability and validity of the short forms (SF) assessment of positive (SAPS) and negative (SANS) symptoms scales. Methods: In 235 Spanish schizophrenia outpatients, accuracy of the SF for measuring clinical remission (for at least 6 months) was assessed in comparison with the standard forms. Results: For the SF overall score, Cronbach's alpha was 0.78. Correlations with the standard form were 0.89, both cross-sectionally and longitudinally (0- to 12-month change scores). Using a cut-off score of 16, remission assessed by the SF had a sensitivity of 100% and a specificity of 72%. When using a cut-off score of 8, both sensitivity and specificity were 86%. Conclusions: The short forms of the SAPS and the SANS are reliable and have face validity for assessing remission of schizophrenia outpatients. They should be considered for use in routine clinical practice.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 10 条
[1]   A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia [J].
Alvarez, Enrique ;
Ciudad, Antonio ;
Olivares, Jose Manuel ;
Bousono, Manuel ;
Gomez, Juan Carlos .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (03) :238-249
[2]   Remission in schizophrenia: Proposed criteria and rationale for consensus [J].
Andreasen, NC ;
Carpenter, WT ;
Kane, JM ;
Lasser, RA ;
Marder, SR ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (03) :441-449
[3]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789
[4]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784
[5]  
CICCHETTI DV, 1983, ARCH GEN PSYCHIAT, V40, P987
[6]   BARRIERS TO THE USE OF HEALTH-STATUS MEASURES IN CLINICAL INVESTIGATION, PATIENT-CARE, AND POLICY RESEARCH [J].
DEYO, RA ;
PATRICK, DL .
MEDICAL CARE, 1989, 27 (03) :S254-S268
[7]   The Clinical Global Impression-Schizophrenia scale:: a simple instrument to measure the diversity of symptoms present in schizophrenia [J].
Haro, JM ;
Kamath, SA ;
Ochoa, S ;
Novick, D ;
Rele, K ;
Fargas, A ;
Rodríguez, MJ ;
Rele, R ;
Orta, J ;
Kharbeng, A ;
Araya, S ;
Gervin, M ;
Alonso, J ;
Mavreas, V ;
Lavrentzou, E ;
Liontos, N ;
Gregor, K ;
Jones, PB .
ACTA PSYCHIATRICA SCANDINAVICA, 2003, 107 :16-23
[8]   The improved Clinical Global Impression Scale (iCGI): development and validation in depression [J].
Kadouri, Alane ;
Corruble, Emmanuelle ;
Falissard, Bruno .
BMC PSYCHIATRY, 2007, 7 (1)
[9]  
LANDIS JR, 1977, BIOMETRICS, V33, P174
[10]  
Rush AJ., 2000, HDB PSYCHIAT MEASURE, V1